Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04430725 · ClinicalTrials.gov registry record

Microwave Ablation or Wedge Resection for the Treatment of Lung, Sarcoma and Colorectal Lesions, ALLUME Study

A clinical trial of Lung Non-Small Cell Carcinoma and Stage II Lung Cancer AJCC v8, sponsored by M.D. Anderson Cancer Center.

Active
Registry status
74
Enrollment target
1
Study location

NCT04430725: Active study of Lung Non-Small Cell Carcinoma and Stage II Lung Cancer AJCC v8, sponsored by M.D. Anderson Cancer Center.

NCT04430725 is a study of Lung Non-Small Cell Carcinoma and Stage II Lung Cancer AJCC v8 that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 74 participants, below the 159-participant average among 47 other Lung Non-Small Cell Carcinoma trials with a reported enrollment target (53% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04430725, a study of Lung Non-Small Cell Carcinoma and Stage II Lung Cancer AJCC v8, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.

ACTIVE NOT RECRUITING
Registry status
74 participants
Enrollment target
1
Study location

Study Summary

This study compares the outcomes and safety of two standard treatment options called microwave ablation and surgical wedge resection in patients with non-small cell lung cancer, sarcoma and colorectal cancer that has spread to other parts of the body (metastatic). Microwave ablation is designed to kill tumor cells by heating the tumor until the tumor cells die. A wedge resection is a procedure that involves the surgical removal of a small, wedge-shaped piece of lung tissue to remove a small tumor or to diagnose lung cancer. Comparing these two treatment options may help researchers learn which method works better for the treatment of non-small cell lung cancer, metastatic sarcoma, and metastatic colorectal cancer.

Conditions Studied

Lung Non-Small Cell Carcinoma Stage II Lung Cancer AJCC v8 Metastatic Colorectal Carcinoma Stage I Lung Cancer AJCC v8 Metastatic Sarcoma Stage IIA Lung Cancer AJCC v8 Stage IB Lung Cancer AJCC v8 Stage IA1 Lung Cancer AJCC v8 Stage IA2 Lung Cancer AJCC v8 Stage IA3 Lung Cancer AJCC v8

Interventions

  • OTHER Questionnaire Administration
  • PROCEDURE Computed Tomography with Contrast
  • PROCEDURE Microwave Ablation
  • PROCEDURE Wedge Excision

Study Locations (1)

Texas

  • M D Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 74 participants
Start Date 2019-08-07
Est. Completion 2026-01-01

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04430725

The ClinicalTrials.gov registry entry for NCT04430725 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 159-participant average among 47 other Lung Non-Small Cell Carcinoma trials with a reported enrollment target (53% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 10 conditions, with Lung Non-Small Cell Carcinoma appearing as the primary indexed condition, and to 4 interventions - of which Questionnaire Administration is the first listed.

NCT04430725 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT04430725 about?

NCT04430725 is a clinical study titled "Microwave Ablation or Wedge Resection for the Treatment of Lung, Sarcoma and Colorectal Lesions, ALLUME Study". This study compares the outcomes and safety of two standard treatment options called microwave ablation and surgical wedge resection in patients with non-small cell lung cancer, sarcoma and colorectal cancer that has spread to other parts of the body (metastatic). Microwave ablation is designed to k...

What is the current status of trial NCT04430725?

This trial is currently active not recruiting. The enrollment target is 74 participants. The study started on 2019-08-07. Estimated completion is 2026-01-01.

What conditions does trial NCT04430725 study?

This clinical trial studies the following conditions: Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Metastatic Colorectal Carcinoma, Stage I Lung Cancer AJCC v8, Metastatic Sarcoma.

What interventions are being tested in trial NCT04430725?

The interventions under investigation include: Questionnaire Administration (OTHER), Computed Tomography with Contrast (PROCEDURE), Microwave Ablation (PROCEDURE), Wedge Excision (PROCEDURE).

Who is sponsoring clinical trial NCT04430725?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04430725 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Lung Non-Small Cell Carcinoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Lung Non-Small Cell Carcinoma

All registered trials for this condition

Stage II Lung Cancer AJCC v8

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.